Beneficial Cardiovascular Pleiotropic Effects of Statins

By J. Davignon. Circulation, 2004

923 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/241d14512c6c1ab7662e9ebf210a372ac92c7f4d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Rhian M. Touyz
2. Marja-Riitta Taskinen
3. I. Graham
4. Jaspinder Kaur
5. Gerhard Hindricks
6. Stephan Windecker

In Surgery

1. I. Graham
2. Marja-Riitta Taskinen
3. Jaspinder Kaur
4. Alberico L. Catapano
5. Ulrich Laufs

Citations in the corpus

• 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. (2019, background): “Although reduction of LDL-C levels is the major effect of statins, a number of other, potentially important effects have been suggested (pleiotropic effects of statins).(204,205) Among such effects that are potentially relevant for the prevention of CVD are the antiinflammatory and antioxidant effec”
• A Comprehensive Review on Metabolic Syndrome (2014, background): “Non-lipid-lowering or pleiotropic effects of statins have also been implicated in their beneficial effects on inflammation, endothelial function, and CVD events [179] and may therefore be beneficial for individuals with the MetS [180].”
• 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. (2016, background): “Although the reduction of LDL-C is the major effect of statins, a number of other, potentially important effects have been suggested (pleiotropic effects of statins).(201,202) Among such effects that are potentially relevant for the prevention of CVD are anti-inflammatory and anti-oxidant effects of”